This inventor holds 1 USPTO granted patent. Top assignees: Allergan, Inc., Exonhit Therapeutics, Sa. Active years: 2016.
Company Filing History:
1 out of 2,287 
1 out of 25 Years Active: 2016
Title: Fabien (Jacques) Schweighoffer: Innovator in Analgesic Compounds
Introduction
Fabien (Jacques) Schweighoffer is a notable inventor based in Fontenay Sous Bois, France. He has made significant contributions to the field of analgesics, particularly through his innovative patent that focuses on specific compounds with pain-relieving properties. His work has implications for treating mammals in need of analgesic treatment.
Latest Patents
Schweighoffer holds a patent for "Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds." This patent describes compounds that exhibit analgesic effects and outlines their use in compositions and methods for treating mammals requiring such treatment. The structural formulas associated with these compounds demonstrate their potential effectiveness in pain management.
Career Highlights
Throughout his career, Schweighoffer has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Exonhit Therapeutics and Allergan, Inc. His experience in these organizations has contributed to his expertise in developing innovative therapeutic solutions.
Collaborations
Schweighoffer has collaborated with esteemed colleagues, including John E. Donello and Thierry Taverne. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Fabien (Jacques) Schweighoffer is a distinguished inventor whose work in analgesic compounds has the potential to impact pain management significantly. His contributions through patents and collaborations highlight his commitment to advancing medical science.